EMA/HMA – Publication of the Nanotechnology-based medicinal products for human use EU-IN Horizon Scanning Report
The Nanotechnology-based medicinal products for human use EU-IN Horizon Scanning Report provides an overview of the current landscape and future trends in nanotechnology-based medicinal products within the European Union. The report highlights the increasing incorporation of nanotechnology in health products, particularly for drug delivery systems, with significant potential in therapeutic areas such as cancer and infectious diseases. It emphasizes the need for a robust regulatory framework to ensure the quality, safety, and efficacy of these products. The EMA has recognized the importance of developing regulatory guidelines specific to nanotechnology-enabled health products to support their successful innovation and market entry. The report also discusses the role of horizon scanning in identifying early signals of relevant innovations and technological trends that may impact medicinal products, helping regulators and policymakers to be better prepared for future developments.
This report is part of the EU Innovation Network (EU-IN) initiative for which you can find more information on the EMA Website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (25 mars 2025). EMA/HMA – Publication of the Nanotechnology-based medicinal products for human use EU-IN Horizon Scanning Report. ELSIBI. Consulté le 18 février 2026 à l’adresse https://doi.org/10.58079/13kgk





